Dynavax Technologies Corp (DVAX)
11.69
-0.15
(-1.27%)
USD |
NASDAQ |
Apr 15, 16:00
11.69
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Total Liabilities (Quarterly): 375.02M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 375.02M |
| September 30, 2023 | 368.02M |
| June 30, 2023 | 359.23M |
| March 31, 2023 | 406.19M |
| December 31, 2022 | 404.84M |
| September 30, 2022 | 498.76M |
| June 30, 2022 | 600.20M |
| March 31, 2022 | 721.49M |
| December 31, 2021 | 816.87M |
| September 30, 2021 | 852.14M |
| June 30, 2021 | 564.53M |
| March 31, 2021 | 390.36M |
| December 31, 2020 | 294.58M |
| September 30, 2020 | 284.11M |
| June 30, 2020 | 271.02M |
| March 31, 2020 | 247.43M |
| December 31, 2019 | 270.78M |
| September 30, 2019 | 261.86M |
| June 30, 2019 | 256.49M |
| March 31, 2019 | 253.44M |
| December 31, 2018 | 147.82M |
| September 30, 2018 | 139.38M |
| June 30, 2018 | 132.55M |
| March 31, 2018 | 129.45M |
| December 31, 2017 | 19.24M |
| Date | Value |
|---|---|
| September 30, 2017 | 13.39M |
| June 30, 2017 | 11.44M |
| March 31, 2017 | 12.74M |
| December 31, 2016 | 20.48M |
| September 30, 2016 | 31.03M |
| June 30, 2016 | 28.84M |
| March 31, 2016 | 25.21M |
| December 31, 2015 | 29.55M |
| September 30, 2015 | 27.72M |
| June 30, 2015 | 34.97M |
| March 31, 2015 | 37.10M |
| December 31, 2014 | 37.81M |
| September 30, 2014 | 25.32M |
| June 30, 2014 | 22.80M |
| March 31, 2014 | 19.73M |
| December 31, 2013 | 18.33M |
| September 30, 2013 | 19.30M |
| June 30, 2013 | 19.35M |
| March 31, 2013 | 21.69M |
| December 31, 2012 | 24.93M |
| September 30, 2012 | 34.76M |
| June 30, 2012 | 31.19M |
| March 31, 2012 | 32.30M |
| December 31, 2011 | 34.22M |
| September 30, 2011 | 28.49M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
247.43M
Minimum
Mar 2020
852.14M
Maximum
Sep 2021
433.89M
Average
375.02M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Supernus Pharmaceuticals Inc | 356.16M |
| Ligand Pharmaceuticals Inc | 86.30M |
| Pacira BioSciences Inc | 704.26M |
| Esperion Therapeutics Inc | 660.79M |
| PetIQ Inc | 645.23M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 997.10M |
| Shareholders Equity (Quarterly) | 622.07M |
| Debt to Equity Ratio | 0.358 |
| Current Ratio | 13.81 |
| Net Debt Paydown Yield | -0.02% |